About Alcyone Therapeutics
Alcyone Therapeutics is a private company based in Lowell, Massachusetts. It has reported $93,160,604 raised in ten offerings on Form D since March 2012. Its chief executive is Pj Anand.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 2023 | Nov 22, 2023amended Jan 8, 2025 | $19,032,812of $31.6M target | 25 | $761K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 8, 2021 | Jun 17, 2021 | $37,103,349fully sold | 31 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Aug 21, 2020 | Sep 2, 2020 | $17,550,174of $19.4M target | 28 | $626K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 21, 2019 | Jul 3, 2019 | $2,208,330of $3.0M target | 17 | $129K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 28, 2019 | Apr 11, 2019 | $1,650,000fully sold | 17 | $97,059 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jan 8, 2018 | Jan 17, 2018 | $5,140,609fully sold | 22 | $233K | EquityRule 506(b) | Form D ↗ |
| Dec 14, 2015 | Dec 24, 2015 | $3,640,319of $3.7M target | 20 | $182K | EquityRule 506(b) | Form D ↗ |
| Dec 31, 2013 | Jan 13, 2014 | $4,000,000fully sold | 19 | $210K | EquityRule 506(b) | Form D ↗ |
| May 9, 2013 | May 20, 2013 | $1,000,004fully sold | 18 | $55,556 | Equity06 | Form D ↗ |
| Dec 29, 2011 | Mar 27, 2012 | $1,835,007of $2.0M target | 14 | $131K | Equity06 | Form D ↗ |
| Total, ten offerings | $93,160,604 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alcyone Therapeutics's Form D filed Jan 8, 2025.
EJ
DD
David Donabedian
Director
Also a director at Anuncia Medical and a founding CEO, newleos therapeutics and director at Neela Therapeutics.
NR
SO
PA
Pj Anand
Chief Executive Officer and director
Also a director at Anuncia Medical, a chief executive officer and director at Arthromeda and a founder, president and chief executive officer, director at Neela Therapeutics.
RU
Richard Upton
Director
Also a director at Anuncia Medical and a partner, harbor light capital partners and director at Neela Therapeutics.
CD
Earlier filings also listed Piratip Pratumsuwan (director, last listed Jun 2021) and Edgard Jannotta, Jr. (director, last listed Jan 2014).